Qiagen NV (NYSE:QGEN)
$ 43.76 -0.39 (-0.88%) Market Cap: 9.73 Bil Enterprise Value: 10.24 Bil PE Ratio: 137.61 PB Ratio: 2.86 GF Score: 87/100

Qiagen NV at Evercore ISI HealthCONx Conference Transcript

Nov 28, 2023 / 05:30 PM GMT
Release Date Price: $42.39 (+1.31%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

QGEN.N - Qiagen NV
Qiagen NV at Evercore ISI HealthCONx Conference
Nov 28, 2023 / 05:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified Company Representative, [1]
--------------------------------------------------------------------------------
(technical difficulty)

there's A, B and C and look at the total cost of ownership to process a test, whether it's HIV, hepatitis C, TB tests or cancer screening, whatever you're trying to get done as a lab, where can I make the highest margin spread in terms of the reimbursement against that business. This is a business that where you have big customers like [QIAseq] LabCorp. You have a lot of regional labs around the world that we're serving. Obviously, our big products here would be QuantiFERON for latent tuberculosis testing. That's approaching $400 million of sales this year. Even though we're barely penetrated only about 35% to 40% penetrated alone in the U.S. on that market. We're also a big player in
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot